These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
541 related items for PubMed ID: 12868123
1. Management of osteoporosis due to ovarian failure. Eastell R. Med Pediatr Oncol; 2003 Sep; 41(3):222-7. PubMed ID: 12868123 [Abstract] [Full Text] [Related]
2. Aging bone and osteoporosis: strategies for preventing fractures in the elderly. Ettinger MP. Arch Intern Med; 2003 Oct 13; 163(18):2237-46. PubMed ID: 14557222 [Abstract] [Full Text] [Related]
3. [Hormone replacement therapy and its derivatives in the prevention and treatment of osteoporosis]. Lamy O, Krieg MA. Rev Med Suisse Romande; 2002 Aug 13; 122(8):377-81. PubMed ID: 12357730 [Abstract] [Full Text] [Related]
4. Management of osteoporosis in postmenopausal women: 2010 position statement of The North American Menopause Society. Menopause; 2010 Aug 13; 17(1):25-54; quiz 55-6. PubMed ID: 20061894 [Abstract] [Full Text] [Related]
5. Osteoporosis: strategies for prevention and management. Keen R. Best Pract Res Clin Rheumatol; 2007 Feb 13; 21(1):109-22. PubMed ID: 17350547 [Abstract] [Full Text] [Related]
7. 7: Treatment of osteoporosis: why, whom, when and how to treat. The single most important consideration is the individual's absolute risk of fracture. Seeman E, Eisman JA. Med J Aust; 2004 Mar 15; 180(6):298-303. PubMed ID: 15012571 [Abstract] [Full Text] [Related]
8. Risk of fracture and treatment to prevent osteoporosis-related fracture in postmenopausal women. A review. Martens MG. J Reprod Med; 2003 Jun 15; 48(6):425-34. PubMed ID: 12856513 [Abstract] [Full Text] [Related]
11. Drug insight: Existing and emerging therapies for osteoporosis. Mulder JE, Kolatkar NS, LeBoff MS. Nat Clin Pract Endocrinol Metab; 2006 Dec 15; 2(12):670-80. PubMed ID: 17143314 [Abstract] [Full Text] [Related]
12. Health-economic comparison of three recommended drugs for the treatment of osteoporosis. Brecht JG, Kruse HP, Möhrke W, Oestreich A, Huppertz E. Int J Clin Pharmacol Res; 2004 Dec 15; 24(1):1-10. PubMed ID: 15575171 [Abstract] [Full Text] [Related]
13. [Raloxifene (Evista) in the treatment of postmenopausal osteoporosis--the profile of the patient]. Kastelan D, Korsić M. Reumatizam; 2005 Dec 15; 52(2):67-70. PubMed ID: 16689133 [Abstract] [Full Text] [Related]
15. [Treatment of osteoporosis: current data and prospects]. Reginster JY, Deroisy R, Franchimont P. Rev Rhum Ed Fr; 1994 Dec 15; 61(10 Pt 2):155S-164S. PubMed ID: 7858567 [Abstract] [Full Text] [Related]
16. Prevention and management of osteoporosis: consensus statements from the Scientific Advisory Board of the Osteoporosis Society of Canada. 6. Use of bisphosphonates in the treatment of osteoporosis. Hodsman A, Adachi J, Olszynski W. CMAJ; 1996 Oct 01; 155(7):945-8. PubMed ID: 8837544 [Abstract] [Full Text] [Related]
17. Strategies for treatment to prevent fragility fractures in postmenopausal women. Geusens P. Best Pract Res Clin Rheumatol; 2009 Dec 01; 23(6):727-40. PubMed ID: 19945685 [Abstract] [Full Text] [Related]
18. The prevention and treatment of osteoporosis: a review. Cosman F. MedGenMed; 2005 May 11; 7(2):73. PubMed ID: 16369451 [Abstract] [Full Text] [Related]
19. [Therapeutic concepts in the treatment of postmenopausal osteoporosis]. Leidig-Bruckner G, Ziegler R. Ther Umsch; 1994 Nov 11; 51(11):737-47. PubMed ID: 7839332 [Abstract] [Full Text] [Related]
20. [Postmenopausal osteoporosis]. László A. Orv Hetil; 2004 Jan 04; 145(1):3-13. PubMed ID: 15222134 [Abstract] [Full Text] [Related] Page: [Next] [New Search]